Drug intelligence / Profile preview

medihoney gel

Development stage: Unknown
Lead developer: Integra LifeSciences
Modality: Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration: Topical

Overview

Medihoney Gel is a medical-grade wound and burn dressing product containing Active Leptospermum (Manuka) Honey. It is composed of 80% medical-grade Active Leptospermum Honey by weight and 20% natural gelling agents. This formulation creates a moist environment conducive to wound healing while providing antimicrobial properties. Key properties include: - Low pH (3.5-4.5) - High osmotic activity - Assists in debridement of necrotic tissue and slough - Provides antimicrobial effects - Offers anti-inflammatory properties and immune stimulation

Brand names: MEDIHONEY GelMediHoney Gel Wound & Burn DressingMediHoney Antimicrobial Wound Gel
Other names: MediHoney Gel with Active Leptospermum Honey

Beyond the preview

Go deeper on medihoney gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on medihoney gel.

Explore the full profile